The Council of the Regions has authorized the NT Council to make recommendations for the use of some new drugs. Imfinz or durvalumab was approved earlier this autumn and can be used in adults treated with locally advanced non-small cell lung cancer that can not be used, but not spread to the body.
Treatment with drug use is considered moderate, but district councils and regions decide it to be implemented as a method of treatment.
Common cancer form
During treatment, the medicine is given intravenously every hour for one hour every two weeks. It is estimated that the patient will pay 96 000 kroons a month.
By 2016, nearly 4,000 Swedes had been diagnosed with lung cancer. Sweden is the sixth most commonly occurring form of cancer, but the most common cause of cancer is death. It is written by AstraZeneca in a press release.